Literature DB >> 33690049

Giant cell arteritis-related aortic dissection: A multicenter retrospective study.

Hubert de Boysson1, Olivier Espitia2, Maxime Samson3, Nathalie Tieulié4, Claude Bachmeyer5, Thomas Moulinet6, Anael Dumont7, Samuel Deshayes7, Bernard Bonnotte3, Christian Agard2, Achille Aouba7.   

Abstract

PURPOSE: To describe characteristics and outcomes of patients with giant cell arteritis (GCA)-related aortic dissection. PATIENTS AND METHODS: We retrospectively included, through a nationwide GCA network, all patients who had an aortic dissection either revealing GCA or occurring during follow-up.
RESULTS: A total of 46 patients were included in this study. Aortic dissection was inaugural and led to GCA diagnosis in 21 patients, whereas it occurred during follow-up in the 25 others, at a median of 53 [1-265] months after GCA diagnosis. Large-vessel vasculitis (LVV) was diagnosed through imaging before or at the time of aortic dissection in 31 (67%) patients. In patients who developed an aortic dissection during follow-up, the aortic event occurred 22 [1-143] months post GCA diagnosis in the patients with previous aortitis, whereas it occurred after 72 [19-265] months in patients without previously diagnosed aortitis (p = 0.005). Aortic surgery was performed in 27 (59%) patients and 23 of them survived. A total of 15 (32%) patients died following the aortic dissection, including 11 who were not operated on. In a multivariate analysis, aortic surgery was the single predictor of survival (HR: 4.3; 95% CI: 1.47- 15.7; p = 0.007).
CONCLUSION: Patients with prior LVV are more prone to develop early aortic dissection and require close monitoring of aortic morphology. One third of patients died from the aortic dissection. Surgery remains the best predictive factor for survival.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic dissection; Aortitis; Giant-cell arteritis; Large-vessel vasculitis; Surgery

Year:  2021        PMID: 33690049     DOI: 10.1016/j.semarthrit.2021.03.001

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  3 in total

Review 1.  An Updated Review of Cardiovascular Events in Giant Cell Arteritis.

Authors:  Hubert de Boysson; Achille Aouba
Journal:  J Clin Med       Date:  2022-02-15       Impact factor: 4.241

2.  Patients' Baseline Characteristics, but Not Tocilizumab Exposure, Affect Severe Outcomes Onset in Giant Cell Arteritis: A Real-World Study.

Authors:  Cyril Dumain; Jonathan Broner; Erik Arnaud; Emmanuel Dewavrin; Jan Holubar; Myriam Fantone; Benoit de Wazières; Simon Parreau; Pierre Fesler; Philippe Guilpain; Camille Roubille; Radjiv Goulabchand
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

3.  ALDH2 knockout protects against aortic dissection.

Authors:  Chentao Luo; Bing Zhou; Yong Cui; Zhifang Liu; Shuwei Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-10-13       Impact factor: 2.174

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.